Comparison of Methods for Visual Field Progression in Eyes With Central Visual Field Defects
Incorporating 10-2 VF testing alongside 24-2 is essential, as relying solely on 24-2 VF may underestimate central VF progression.
Authors
- Sasan Moghimi (ORCID: https://orcid.org/0000-0002-9375-4711)
- Evan Walker (ORCID: https://orcid.org/0000-0001-8566-0371)
- Massimo A. Fazio (ORCID: https://orcid.org/0000-0002-7489-089X)
- Jeffrey M. Liebmann (ORCID: https://orcid.org/0000-0002-5663-0533)
- Takashi Nishida (ORCID: https://orcid.org/0000-0001-8220-2738)
- Robert N. Weinreb
- Christopher A. Girkin (ORCID: https://orcid.org/0000-0002-9676-4499)
Institutions
- University of Alabama at Birmingham (US)
- The California Eye Institute (US)
- Smith-Kettlewell Eye Research Institute (US)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1167/tvst.14.11.3
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- EyeSight Foundation of Alabama
- Research to Prevent Blindness
- Glaucoma Foundation
- Tobacco-Related Disease Research Program
- Carl Zeiss Meditec AG
- Heidelberg Engineering
- National Institutes of Health
- Genentech
- Allergan
- Medical Research Council